Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sadhna J Joglekar"'
Autor:
Rakesh K. Sahay, Richa Giri, Jayashree V. Shembalkar, Sandeep K. Gupta, Brij Mohan, Prakash Kurmi, S. Ravindra Kumar, Vinayak M. Sawardekar, Ashutosh Mishra, L. Sreenivasa Murthy, Vivek V. Arya, Abhijit R. Sonawane, Pravin N. Soni, Sandip K. Gofne, Shital R. Karnawat, Mandodari N. Rajurkar, Piyush M. Patel, Lalit K. Lakhwani, Suyog C. Mehta, Sadhna J. Joglekar
Publikováno v:
Advances in Therapy.
Autor:
Amit B. Yeole, G. Sree Ranga Lakshmi, C. J. Selvakumar, Vijay G. Goni, C. L. Nawal, Bhanoth J. Valya, Brijesh J. Patel, Rohit D. Patel, Eknath D. Pawar, Ranajit Panigrahi, Ashish Y. Kumar, Shrinivas S. Shintre, Prashant H. Devkare, Shruti K. Dharmadhikari, Sanjay Y. Choudhari, Maulik S. Doshi, Suyog C. Mehta, Sadhna J. Joglekar
Publikováno v:
Pain and therapy. 11(4)
Currently available treatments for chronic lower back pain (CLBP) do not adequately address both nociceptive and neuropathic components of pain. We evaluated efficacy and safety of fixed-dose combination (FDC) of low-dose pregabalin prolonged release
Publikováno v:
Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine
Background and Aim: There is lack of substantial Indian data on venous thromboembolism (VTE). The aim of this study was to provide real-world information on patient characteristics, management strategies, clinical outcomes, and temporal trends in VTE
Autor:
Mathew Thomas, Prasanna Kumar, Sanjay Reddy, Sushrut Babhulkar, Vipul Halbe, Sudeep Acharya, B. S. Mody, Naresh Shetty, Antonio Nino, Vaishali Deshmukh, Sadhna J Joglekar, Lorraine A. Fitzpatrick, Jacob Chacko, Barbara G. Kravitz, Gaurav Rathi, Shailesh Pitale, Brian Waterhouse, Atul Kakar
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 1, Pp 148-154 (2015)
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 1, Pp 148-154 (2015)
Introduction: Osteoporosis is a serious condition affecting up to 50% of Indian postmenopausal women. Denosumab reduces bone resorption by targeting the receptor activator of nuclear factor-κB ligand. This study assessed the efficacy and safety of d